Article Text

other Versions

PDF
Correspondence
Primary effusion lymphoma (PEL) without effusion: a patient case report of a PEL solid variant
  1. Clemens Giessen1,
  2. Dorit Di Gioia1,
  3. Bruno Huber2,
  4. Bettina Seppi1,
  5. Anno Graser3,
  6. Hans Roland Duerr4,
  7. Doris Mayr5,
  8. Thomas Kirchner5,
  9. Andreas Rosenwald6,
  10. Roswitha Forstpointner1,
  11. Volker Heinemann1,
  12. Johannes R Bogner7,
  13. Helmut Ostermann1
  1. 1Department of Hematology and Oncology, University of Munich, Munich, Germany
  2. 2Department of Cardiology, University of Munich, Munich, Germany
  3. 3Department of Clinical Radiology, University of Munich, Munich, Germany
  4. 4Department of Orthopedics, University of Munich, Munich, Germany
  5. 5Department of Pathology, University of Munich, Munich, Germany
  6. 6Institute of Pathology, University of Wuerzburg, Wuerzburg, Germany
  7. 7Division of Infectious Diseases, Munich, Germany
  1. Correspondence to Dr Clemens Giessen, Department of Hematology and Oncology, University of Munich, Marchioninistrasse 15, Munich 81377, Germany; clemens.giessen{at}med.uni-muenchen.de

Statistics from Altmetric.com

Primary effusion lymphoma (PEL) is a very rare type of lymphoma that is usually confined to the body cavities such as the pleural space, pericardium and peritoneum. PEL is associated with human herpes virus-8 (HHV-8) infection and commonly observed in HIV-infected patients.

We present a case of PEL confirmed by pathology without effusion in a 38-year-old man at initial HIV diagnosis.

A 38-year-old man presented with a right axillary swelling, restricted arm movement and chest pain for 3 weeks. He reported weight loss of 4 kg and night sweat without fever and/or chills. On physical examination, we found enlarged neck and axillary lymph nodes with a diameter of 3 cm, movable and hard presentation without tenderness. Elevation of the right shoulder was restricted to 20° with intact circulation and sensitivity.

Lab reports showed …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.